HEPION PHARMACEUTICALS, INC. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2026-04-22: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2026-04-21; Total offering amount $700,000.
- 2014-10-23: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2014-10-14; Total offering amount $12,500,000.
- 2014-08-22: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2014-08-20; Total offering amount $4,742,648.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|
| 2026-04-22 | Rule 506(b) | Equity | 2026-04-21 | $700,000 | $700,000 | $0 | 11 |
|---|
| 2014-10-23 | Rule 506(b) | Equity | 2014-10-14 | $12,500,000 | $9,000,000 | $3,500,000 | 1 |
|---|
| 2014-08-22 | Rule 506(b) | Equity | 2014-08-20 | $4,742,648 | $4,742,648 | $0 | 19 |
|---|